Open access
0
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer
Approved CAR-T therapies have reproducible efficacy and safety in clinical practice
Daniel Goyco Veraa Department of Medicine, Baylor College of Medicine, Houston, TX, USACorrespondence[email protected]
View further author information
, View further author information
Hiral Waghelaa Department of Medicine, Baylor College of Medicine, Houston, TX, USAView further author information
, Mohamed Nuha Department of Medicine, Baylor College of Medicine, Houston, TX, USAView further author information
, Jonathan Pana Department of Medicine, Baylor College of Medicine, Houston, TX, USAView further author information
& Premal Lullaa Department of Medicine, Baylor College of Medicine, Houston, TX, USA;b Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children’s Hospital, Houston, TX, USAView further author information
Article: 2378543
|
Received 24 Apr 2024, Accepted 07 Jul 2024, Published online: 05 Aug 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.